MED16 Antikörper
Kurzübersicht für MED16 Antikörper (ABIN7117669)
Target
Alle MED16 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- MED16 antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- polymerase(RNA) I polypeptide D, 16kDa
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:2000, IF: 1:20-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months
-
Haltbarkeit
- 12 months
-
-
- MED16 (Mediator Complex Subunit 16 (MED16))
-
Andere Bezeichnung
- MED16
-
Hintergrund
-
Synonyms: Mediator of RNA polymerase II transcription subunit 16|Mediator complex subunit 16|Thyroid hormone receptor-associated protein 5|Thyroid hormone receptor-associated protein complex 95 kDa component (Trap95)|Vitamin D3 receptor-interacting protein complex 92 kDa component (DRIP92)|MED16|DRIP92|THRAP5
Background: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Common core component of RNA polymerases I and III which synthesize ribosomal RNA precursors and small RNAs, such as 5S rRNA and tRNAs, respectively.
-
Molekulargewicht
- 16 kDa
-
Gen-ID
- 51082
-
UniProt
- Q9Y2S0
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Nuclear Hormone Receptor Binding, Regulation of Lipid Metabolism by PPARalpha
Target
-